Please login to the form below

Not currently logged in
Email:
Password:

Biocon in drug development talks with Bayer

According to a report in the Indian newspaper, The Economic Times, biotechnology company, Biocon, is in discussions with German pharmaceutical company Bayer regarding the co-development of biotechnology drugs.

According to a report in the Indian newspaper, The Economic Times, biotechnology company, Biocon, is in discussions with German pharmaceutical company Bayer regarding the co-development of biotechnology drugs.

Biocon's managing director and chairman, Kiran Mazumdar-Shaw, told the newspaper that the agreement, which initially involved research activities, could also include biotech drug development activities.

Biocon, which has not commented on the report, derives much of its revenue from ethical drugs, such as head and neck cancer treatment, BioMab EGFR, as well as its enzyme business. The firm's strategy is to increase the share of research services business to a quarter of its total revenue in the next five years from about 15 per cent currently.

Bristol-Myers Squibb (BMS) revealed back in March 2007 that it was to partner with Biocon's research services unit, Sungene, and set up a facility in Bangalore to aid discovery and early drug development.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics